An interventional study of LiquiBand Exceed and LiquiBand Rapid in Surgical Wound, sponsored by Advanced Medical Solutions Ltd.. Completed at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-28.
Sponsored by Advanced Medical Solutions Ltd. · Not applicable, Interventional, and Other
The purpose of this post market study is to evaluate the performance and safety of LiquiBand® Exceed™ and LiquiBand® Rapid™ for closure of surgical incisions associated with abdominal surgery.
LiquiBand® Exceed™ and LiquiBand® Rapid™ are the "study" devices. The study devices are an adhesive used to close surgical wounds. When the adhesive is applied to the skin, it polymerizes (forms a chemical bond) within minutes due to the moisture on the skin's surface and allows the wound edges to remain in the correct position. The use of the study devices are not "investigational" (experimental) because it is already cleared for doctors to use for surgical wound closure in the United States of America.
In this study, LiquiBand® Exceed™ and LiquiBand® Rapid™ will be used to close surgical wounds following general abdominal surgery. Subjects will be followed up for 14-days post surgery, and safety and performance of the study device will be evaluated.
519 studies on the registry are indexed under Surgical Wound; 71 are open to participants now.
This study's enrollment of 101 is above the median of 80 across 412 interventional studies indexed under Surgical Wound.
Browse Surgical Wound studies →Advanced Medical Solutions Ltd. is the lead sponsor of 14 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who meet all of these criteria at time of enrollment may be included in the investigation:
Exclusion Criteria:
Patients who meet any one of these criteria will be excluded from the study:
Surgical wound closure using the LiquiBand Exceed Topical Skin Adhesive
Device: LiquiBand Exceed
Surgical wound closure using the LiquiBand Rapid Topical Skin Adhesive
Device: LiquiBand Rapid
Cyanoacrylate glue for closure of surgical wounds
Cyanoacrylate glue for closure of surgical wounds
Incidence of wound dehiscence
Proportion of subjects with evidence of partial or complete dehiscence assessed by the investigator
Time frame: 14 days post-surgery
Safety of Liquiband Exceed, assessed by incidence of device-related AEs / SAEs
Proportion of subjects who experience at least one device-related AE/SAE
Time frame: 14-days post-surgery
Surgeon satisfaction with the device
To be assessed by the investigator using a Likert scale at the time of surgery
Time frame: Day 0
Cosmetic outcome
Investigator assessment of wound cosmesis using the Modified Hollander Wound Evaluation Scale (HWES). This will be modified to a 6-point scale with one point assigned to any of the following observed wound appearances: step-off borders, contour irregularities, margin separation, edge inversion, excessive distortion, and overall appearance of wound. A HWES of 0 will indicate an optimal wound appearamce, with each point between 1 and 6 indicating a less adequate appearance of the wound.
Time frame: 14-days post-surgery
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Advanced Medical Solutions Ltd.